Skip to main navigation
Skip to content
Contact Us
Millendo
  • Our Story
  • Our Patients
    • Clinical Research Overview
    • MLE-301 Clinical Study
    • Educational Resources and Advocacy
    • Compassionate Use
  • Our Science
    • Pipeline
    • Disease Areas
    • MLE-301
  • Investors & Media
    • Overview
    • News & Events
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
    • Annual Reports & SEC Filings
    • Investor Resources
  • Join Our Team
Contact Us
Millendo
  • Our Story
  • Our Patients
    • Clinical Research Overview
    • MLE-301 Clinical Study
    • Educational Resources and Advocacy
    • Compassionate Use
  • Our Science
    • Pipeline
    • Disease Areas
    • MLE-301
  • Investors & Media
    • Overview
    • News & Events
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
    • Annual Reports & SEC Filings
    • Investor Resources
  • Join Our Team
Investor Calendar
  • News
  • Event Calendar & Presentations

Millendo Therapeutics at H.C. Wainwright 22nd Annual Global Investment Conference (Virtual)

Sep 16, 2020 at 1:30 PM EDT

Click here for webcast

Shareholder Tools

Print Page Email Page RSS Feeds Email Alerts Financial Tear Sheet

US Offices

Corporate Headquarters

110 Miller Avenue, Suite 100
Ann Arbor, MI 48104
734-845-9000
millendo@millendo.com

Europe Office

 
Lyon Office

Millendo Therapeutics SAS
c/o Canopee consulting
8 rue Berjon
69009 Lyon
France
Tel +33 472 18 94 28

  • Our Story
  • Our Patients
  • Our Science
  • Investors & Media
  • Join Our Team
  • Privacy Policy
Copyright © 2020 Millendo Therapeutics, Inc. All rights reserved.
Scroll to Top